Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-040280
Filing Date
2025-03-17
Accepted
2025-03-17 16:15:38
Documents
124
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fgen-20241231.htm   iXBRL 10-K 4847517
2 EX-10.5 fgen-ex10_5.htm EX-10.5 85162
3 EX-10.6 fgen-ex10_6.htm EX-10.6 78091
4 EX-23.1 fgen-ex23_1.htm EX-23.1 2601
5 EX-31.1 fgen-ex31_1.htm EX-31.1 12205
6 EX-31.2 fgen-ex31_2.htm EX-31.2 12426
7 EX-32.1 fgen-ex32_1.htm EX-32.1 8171
  Complete submission text file 0000950170-25-040280.txt   20906153

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20241231.xsd EX-101.SCH 3237235
127 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20241231_htm.xml XML 3889294
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36740 | Film No.: 25744623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)